Walgreen, CalPERS Lobby FDA To Drop Biosimilars Naming
A coalition of 32 major pharmacies, unions, health insurers and pension plans on Tuesday urged the U.S. Food and Drug Administration not to require distinct names for each version of a...To view the full article, register now.
Already a subscriber? Click here to view full article